Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 21

1.

Extracellular adenosine promotes cell migration/invasion of Glioblastoma Stem-like Cells through A3 Adenosine Receptor activation under hypoxia.

Torres Á, Erices JI, Sanchez F, Ehrenfeld P, Turchi L, Virolle T, Uribe D, Niechi I, Spichiger C, Rocha JD, Ramirez M, Salazar-Onfray F, San Martín R, Quezada C.

Cancer Lett. 2019 Apr 1;446:112-122. doi: 10.1016/j.canlet.2019.01.004. Epub 2019 Jan 18.

PMID:
30660649
2.

[Cancer stem cells in glioblastoma].

Virolle T.

Bull Cancer. 2017 Dec;104(12):1075-1079. doi: 10.1016/j.bulcan.2017.10.012. Epub 2017 Nov 16. Review. French. No abstract available.

PMID:
29153545
3.

Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.

Bogeas A, Morvan-Dubois G, El-Habr EA, Lejeune FX, Defrance M, Narayanan A, Kuranda K, Burel-Vandenbos F, Sayd S, Delaunay V, Dubois LG, Parrinello H, Rialle S, Fabrega S, Idbaih A, Haiech J, Bièche I, Virolle T, Goodhardt M, Chneiweiss H, Junier MP.

Acta Neuropathol. 2018 Feb;135(2):267-283. doi: 10.1007/s00401-017-1783-x. Epub 2017 Nov 17.

4.

[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression.

Dadone-Montaudié B, Ambrosetti D, Dufour M, Darcourt J, Almairac F, Coyne J, Virolle T, Humbert O, Burel-Vandenbos F.

PLoS One. 2017 Sep 22;12(9):e0184625. doi: 10.1371/journal.pone.0184625. eCollection 2017.

5.

Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.

Fareh M, Almairac F, Turchi L, Burel-Vandenbos F, Paquis P, Fontaine D, Lacas-Gervais S, Junier MP, Chneiweiss H, Virolle T.

Cell Death Dis. 2017 Mar 30;8(3):e2713. doi: 10.1038/cddis.2017.117.

6.

A driver role for GABA metabolism in controlling stem and proliferative cell state through GHB production in glioma.

El-Habr EA, Dubois LG, Burel-Vandenbos F, Bogeas A, Lipecka J, Turchi L, Lejeune FX, Coehlo PL, Yamaki T, Wittmann BM, Fareh M, Mahfoudhi E, Janin M, Narayanan A, Morvan-Dubois G, Schmitt C, Verreault M, Oliver L, Sharif A, Pallud J, Devaux B, Puget S, Korkolopoulou P, Varlet P, Ottolenghi C, Plo I, Moura-Neto V, Virolle T, Chneiweiss H, Junier MP.

Acta Neuropathol. 2017 Apr;133(4):645-660. doi: 10.1007/s00401-016-1659-5. Epub 2016 Dec 28.

7.

Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers.

Papin-Michault C, Bonnetaud C, Dufour M, Almairac F, Coutts M, Patouraux S, Virolle T, Darcourt J, Burel-Vandenbos F.

PLoS One. 2016 Jun 8;11(6):e0157139. doi: 10.1371/journal.pone.0157139. eCollection 2016.

8.

A Positive Feed-forward Loop Associating EGR1 and PDGFA Promotes Proliferation and Self-renewal in Glioblastoma Stem Cells.

Sakakini N, Turchi L, Bergon A, Holota H, Rekima S, Lopez F, Paquis P, Almairac F, Fontaine D, Baeza-Kallee N, Van Obberghen-Schilling E, Junier MP, Chneiweiss H, Figarella-Branger D, Burel-Vandenbos F, Imbert J, Virolle T.

J Biol Chem. 2016 May 13;291(20):10684-99. doi: 10.1074/jbc.M116.720698. Epub 2016 Mar 21.

9.

Cells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practice.

Burel-Vandenbos F, Turchi L, Benchetrit M, Fontas E, Pedeutour Z, Rigau V, Almairac F, Ambrosetti D, Michiels JF, Virolle T.

Neuro Oncol. 2013 Oct;15(10):1278-88. doi: 10.1093/neuonc/not094. Epub 2013 Aug 9.

10.

The relationship between brain tumor cell invasion of engineered neural tissues and in vivo features of glioblastoma.

Nayernia Z, Turchi L, Cosset E, Peterson H, Dutoit V, Dietrich PY, Tirefort D, Chneiweiss H, Lobrinus JA, Krause KH, Virolle T, Preynat-Seauve O.

Biomaterials. 2013 Nov;34(33):8279-90. doi: 10.1016/j.biomaterials.2013.07.006. Epub 2013 Jul 27.

PMID:
23899445
11.

Tumorigenic potential of miR-18A* in glioma initiating cells requires NOTCH-1 signaling.

Turchi L, Debruyne DN, Almairac F, Virolle V, Fareh M, Neirijnck Y, Burel-Vandenbos F, Paquis P, Junier MP, Van Obberghen-Schilling E, Chneiweiss H, Virolle T.

Stem Cells. 2013 Jul;31(7):1252-65. doi: 10.1002/stem.1373.

12.

EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.

Burel-Vandenbos F, Benchetrit M, Miquel C, Fontaine D, Auvergne R, Lebrun-Frenay C, Cardot-Leccia N, Michiels JF, Paquis-Flucklinger V, Virolle T.

J Neurooncol. 2011 Apr;102(2):171-8. doi: 10.1007/s11060-010-0308-4. Epub 2010 Jul 24.

PMID:
20652725
13.

Embryonic stem cells as an ectodermal cellular model of human p63-related dysplasia syndromes.

Rostagno P, Wolchinsky Z, Vigano AM, Shivtiel S, Zhou H, Van Bokhoven H, Ferone G, Missero C, Mantovani R, Aberdam D, Virolle T.

Biochem Biophys Res Commun. 2010 Apr 23;395(1):131-5. doi: 10.1016/j.bbrc.2010.03.154. Epub 2010 Mar 30.

PMID:
20361935
14.

Development of human nervous tissue upon differentiation of embryonic stem cells in three-dimensional culture.

Preynat-Seauve O, Suter DM, Tirefort D, Turchi L, Virolle T, Chneiweiss H, Foti M, Lobrinus JA, Stoppini L, Feki A, Dubois-Dauphin M, Krause KH.

Stem Cells. 2009 Mar;27(3):509-20. doi: 10.1634/stemcells.2008-0600.

15.

DeltaNp63 is essential for epidermal commitment of embryonic stem cells.

Medawar A, Virolle T, Rostagno P, de la Forest-Divonne S, Gambaro K, Rouleau M, Aberdam D.

PLoS One. 2008;3(10):e3441. doi: 10.1371/journal.pone.0003441. Epub 2008 Oct 17.

16.

HIF1 transcription factor regulates laminin-332 expression and keratinocyte migration.

Fitsialos G, Bourget I, Augier S, Ginouvès A, Rezzonico R, Odorisio T, Cianfarani F, Virolle T, Pouysségur J, Meneguzzi G, Berra E, Ponzio G, Buscà R.

J Cell Sci. 2008 Sep 15;121(Pt 18):2992-3001. doi: 10.1242/jcs.029256. Epub 2008 Aug 19.

17.

Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.

Buscà R, Berra E, Gaggioli C, Khaled M, Bille K, Marchetti B, Thyss R, Fitsialos G, Larribère L, Bertolotto C, Virolle T, Barbry P, Pouysségur J, Ponzio G, Ballotti R.

J Cell Biol. 2005 Jul 4;170(1):49-59. Epub 2005 Jun 27.

18.

NF-kappaB/Egr-1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death.

Thyss R, Virolle V, Imbert V, Peyron JF, Aberdam D, Virolle T.

EMBO J. 2005 Jan 12;24(1):128-37. Epub 2004 Dec 16.

19.

Inhibition of Egr-1 expression reverses transformation of prostate cancer cells in vitro and in vivo.

Baron V, De Gregorio G, Krones-Herzig A, Virolle T, Calogero A, Urcis R, Mercola D.

Oncogene. 2003 Jul 3;22(27):4194-204.

PMID:
12833142
20.

Egr1 promotes growth and survival of prostate cancer cells. Identification of novel Egr1 target genes.

Virolle T, Krones-Herzig A, Baron V, De Gregorio G, Adamson ED, Mercola D.

J Biol Chem. 2003 Apr 4;278(14):11802-10. Epub 2003 Jan 29.

Supplemental Content

Loading ...
Support Center